What Happens When Your CRO Is Acquired? A Vendor Oversight Approach And Response
Source: Harbor Clinical

M&A deals can be extremely beneficial for small CROs. Being purchased by a larger entity reduces financial uncertainty while presenting opportunities to scale. Likewise, these acquisitions expose small CROs to additional markets and clients. However, M&A deals can also cause disruption, as teams converge and processes intersect, and these growing pains are often felt by sponsors.
In this paper, we look at the growing M&A trend, highlight some of the challenges that M&A deals present, and discuss how investing in vendor oversight services can ensure quality, timeliness, and peace of mind.
VIEW THE ARTICLE!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Harbor Clinical
This website uses cookies to ensure you get the best experience on our website. Learn more